Perimenopausal use of hormone therapy is associated with enhanced memory and hippocampal function later in life

Brain Research

Volumn 1379, Issue , 2011, Pages 232-243

  Maki, Pauline M ^a   Dennerstein, Lorraine ^b   Clark, Margaret ^b   Guthrie, Janet ^b   Lamontagne, Pamela ^a   Fornelli, Deanne ^a   Little, Deborah ^c   Henderson, Victor W ^d   Resnick, Susan M ^e  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c University of Melbourne ^*  (United States)

^d STANFORD UNIVERSITY   (United States)

^e NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Estrogen; fMRI; Hippocampus; Hormone therapy; Memory; Menopause

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; MEDROXYPROGESTERONE ACETATE; TIBOLONE;

ADULT; AGE; AGED; ARTICLE; BRAIN FUNCTION; CLIMACTERIUM; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIPPOCAMPUS; HORMONAL THERAPY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PARAHIPPOCAMPAL GYRUS; PRIORITY JOURNAL; TEMPORAL LOBE; VERBAL MEMORY; VISUAL MEMORY; WORD RECOGNITION;

AGE FACTORS; AGED; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; HIPPOCAMPUS; HORMONE REPLACEMENT THERAPY; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MEMORY; MIDDLE AGED; PERIMENOPAUSE; PROSPECTIVE STUDIES;

EID: 79952312044     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.11.030     Document Type: Article

References (44)

1. Andresen, E.M., et al., 1994. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am. J. Prev. Med. 10, 77-84.
2. Berent-Spillson, A., et al., 2010. Early menopausal hormone use influences brain regions used for visual working memory. Menopause 17, 696-699.
3. Brett, K., Chong, Y., 2001. Hormone Replacement Therapy: Knowledge and Use in the United States. National Center for Health Statistics, Hyattsville, Maryland.
4. Cabeza, R., Nyberg, L., 2000. Imaging cognition II: an empirical review of 275 PET and fMRI studies. J. Cogn. Neurosci. 12, 1-47.
5. Clark, M.S., et al., 2004. Normative verbal and non-verbal memory test scores for Australian women aged 56-67. Aust. N. Z. J. Psychiatry 38, 532-540.
6. Collie, A., et al., 1999. Norms and the effects of demographic variables on a neuropsychological battery for use in healthy ageing Australian populations. Aust. N. Z. J. Psychiatry 33, 568-575.
7. Corporation, T.P., 1997. The WAIS-III-WMS-III Technical Manual. Harcourt-Brace, San Antonio, TX.
8. Delis, D., et al., 2000. California Verbal Learning Test, Adult Version Manualsecond ed. Psychological Corporation, Harcourt-Brace, San Antonio, TX.
9. den Tonkelaar, I., 1997. Validity and reproducibility of self-reported age at menopause in women participating in the DOM-project. Maturitas 27, 117-123.
10. Dennerstein, L., et al., 1993. Menopausal symptoms in Australian women. Med. J. Aust. 159, 232-236.
11. Donaldson, D.I., et al., 2001. Dissociating state and item components of recognition memory using fMRI. Neuroimage 13, 129-142. (Pubitemid 34188251)
12. Erickson, K.I., et al., 2010. A cross-sectional study of hormone treatment and hippocampal volume in postmenopausalwomen: evidence for a limited window of opportunity. Neuropsychology 24, 68-76.
13. Espeland, M.A., et al., 2009. Brain volumes, cognitive impairment, and conjugated equine estrogens. J. Gerontol. A Biol. Sci. Med. Sci. 64, 1243-1250.
14. Gibbs, R.B., 2000. Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats. Neurobiol. Aging 21, 107-116. (Pubitemid 30224792)
15. Greendale, G.A., et al., 2009. Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology 72, 1850-1857.
16. Henderson, V.W., 2009. Aging, estrogens, and episodic memory in women. Cogn. Behav. Neurol. 22, 205-214.
17. Henderson, V., et al., 2003a. Estrogen exposures and memory at midlife: a population-based study of women. Neurology 60, 1369-1371. (Pubitemid 36461000)
18. Henderson, V.W., et al., 2003b. Estrogen exposures and memory at midlife: a population-based study of women. Neurology 60, 1369-1371. (Pubitemid 36461000)
19. Joffe, H., et al., 2006. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women. Menopause 13, 411-422.
20. Kang, J.H., et al., 2004. Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women. Neurology 63, 101-107. (Pubitemid 38943786)
21. Lancaster, J.L., et al., 2000. Automated Talairach atlas labels for functional brain mapping. Hum. Brain Mapp. 10, 120-131.
22. Maki, P.M., Resnick, S.M., 2000. Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol. Aging 21, 373-383. (Pubitemid 30387097)
23. Maki, P.M., Sundermann, E., 2009. Hormone therapy and cognitive function. Hum. Reprod. Update 15, 667-681.
24. Maki, P.M., et al., 2007. Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial. Neurology 69, 1322-1330. (Pubitemid 47482446)
25. Maki, P.M., et al., 2008. Objective hot flashes are negatively related to verbal memory performance in midlife women. Menopause 15, 848-856.
26. Maldjian, J.A., et al., 2003. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 19, 1233-1239. (Pubitemid 36918259)
27. Nelson, H.E., O'Connell, A., 1978. Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test. Cortex 14, 234-244. (Pubitemid 8386900)
28. Persad, C.C., et al., 2009. Enhanced neuroactivation during verbal memory processing in postmenopausal women receiving short-term hormone therapy. Fertil. Steril. 92, 197-204.
29. Phillips, S.M., Sherwin, B.B., 1992. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 17, 485-495. (Pubitemid 23015018)
30. Resnick, S.M., Henderson, V.W., 2002. Hormone therapy and risk of Alzheimer disease: a critical time. JAMA 288.
31. Resnick, S.M., et al., 1998. Estrogen effects on PET cerebral blood flow and neuropsychological performance. Horm. Behav. 34, 171-184.
32. Resnick, S.M., et al., 2004. The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline. Clin. Trials 1, 440-450.
33. Resnick, S.M., et al., 2006. Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J. Clin. Endocrinol. Metab. 91, 1802-1810.
34. Resnick, S.M., et al., 2009. Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study. Neurology 72, 135-142.
35. Rossouw, J.E., et al., 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288, 321-333. (Pubitemid 34761611)
36. Schacter, D.L., Wagner, A.D., 1999. Medial temporal lobe activations in fMRI and PET studies of episodic encoding and retrieval. Hippocampus 9, 7-24. (Pubitemid 29129356)
37. Scherr, P.A., et al., 1988. Correlates of cognitive function in an elderly community population. Am. J. Epidemiol. 128, 1084-1101.
38. Sherwin, B.B., 1988. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 13, 345-357.
39. Silva, I., et al., 2003. Onset of estrogen replacement has a critical effect on synaptic density of CA1 hippocampus in ovariectomized adult rats. Menopause 10, 406-411.
40. Talairach, J., Tournoux, P., 1988. Co-planar Stereotaxic Atlas of the Human Brain. Thieme Medical Publishers, New York.
41. Thurstone, L., Thurstone, T., 1962. Primary Mental Abilities. Science Research Associates, Chicago.
42. Tzourio-Mazoyer, N., et al., 2002. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15, 273-289. (Pubitemid 34852226)
43. Welsh, K.A., et al., 1994. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology 44, 609-614.
44. West, S.L., et al., 1995. Recall accuracy for prescription medications: self-report compared with database information. Am. J. Epidemiol. 142, 1103-1112.